Abstract
Acute lung injury (ALI) is characterized by alveolar injury and uncontrolled inflammation. Mechanisms underlying pathogenesis of ALI are unknown. Regulatory T cells (Tregs), either natural or induced, suppress a variety of physiological and pathological immune responses. In the current study, we investigated whether Tregs were involved in the development of ALI. Proportion of CD4 + CD25 + FoxP3+ Tregs in the peripheral blood of 66 ALI patients and 30 healthy controls were examined by flow cytometry. Data showed that the percentage of Tregs in CD4+ T cells was significantly increased in patients than that in controls (10.8 versus 7.6 %, P = 0.003). Also, compared to those who died during the study, patients who survived presented significantly higher level of Tregs at the time of recruitment (P = 0.041). Since Tim-3 is a negative regulatory molecule and can modulate the function of Tregs, we evaluated Tim-3 level on Tregs and identified upregulation of the molecule in patients than that in controls. Moreover, compared to those who died during the study, patients who survived showed 1.7-fold higher level of Tim-3 on Tregs at the time of recruitment (P < 0.001). These results suggest that Tregs could affect the prognosis of ALI probably due to the upregulation of Tim-3.
Similar content being viewed by others
References
Stephens, R.S., A.S. Shah, and G.J. Whitman. 2013. Lung injury and acute respiratory distress syndrome after cardiac surgery. The Annals of Thoracic Surgery 95: 1122–1129.
Kallet, R.H., and M.A. Matthay. 2013. Hyperoxic acute lung injury. Respiratory Care 58: 123–141.
Eves, N.D., N.D. Eves, Y. Song, A. Piper, and T.M. Maher. 2013. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology (Carlton, Vic.) 18: 555–564.
D’Alessio, F.R., K. Tsushima, N.R. Aggarwal, E.E. West, M.H. Willett, M.F. Britos, M.R. Pipeling, R.G. Brower, R.M. Tuder, J.F. McDyer, and L.S. King. 2009. CD4 + CD25 + Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. The Journal of Clinical Investigation 119: 2898–2913.
Sakaguchi, S., K. Wing, and M. Miyara. 2007. Regulatory T cells - a brief history and perspective. European Journal of Immunology 37(Suppl 1): S116–123.
Ni Choileain, N., M. MacConmara, Y. Zang, T.J. Murphy, J.A. Mannick, and J.A. Lederer. 2006. Enhanced regulatory T cell activity is an element of the host response to injury. Journal of Immunology (Baltimore, Md. : 1950) 176: 225–236.
D’Angelo, C., A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R.G. Iannitti, S. Zagarella, S. Bozza, S. Campo, G. Salvatori, and L. Romani. 2009. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. Journal of Immunology (Baltimore, Md. : 1950) 183: 4609–4618.
Monney, L., C.A. Sabatos, J.L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E.A. Greenfield, A.J. Coyle, R.A. Sobel, G.J. Freeman, and V.K. Kuchroo. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536–541.
Bai, J., X. Li, D. Tong, W. Shi, H. Song, and Q. Li. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 34: 805–809.
Song, H., S. Ma, Z. Cha, L. Chen, D. Tong, L. Ma, W. Song, and J. Bai. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation 36: 793–799.
Fernandez-Ponce, C., M. Dominguez-Villar, E. Aguado, and F. Garcia-Cozar. 2014. CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells. PLoS One 9: e85191.
Wang, J.P., Y. Zhang, X. Wei, J. Li, X.P. Nan, H.T. Yu, Y. Li, P.Z. Wang, and X.F. Bai. 2010. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 118: 261–270.
Cai, L., Y. Fu, and Y. Zhang. 2014. APE1 Asp148Glu polymorphism and lung cancer susceptibility. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5237–5244.
Gu, X.Y., J. Wang, Y.Z. Luo, Q. Du, R.R. Li, H. Shi, and T.P. Yu. 2014. Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5287–5293.
Han, S., S. Feng, L. Xu, W. Shi, X. Wang, H. Wang, C. Yu, T. Dong, M. Xu, and G. Liang. 2014. Tim-3 on peripheral CD4(+) and CD8(+) T cells is involved in the development of glioma. DNA and Cell Biology 33: 245–250.
Wu, J., C. Liu, S. Qian, and H. Hou. 2013. The expression of Tim-3 in peripheral blood of ovarian cancer. DNA and Cell Biology 32: 648–653.
Lee, J., E.J. Park, J.W. Noh, J.W. Hwang, E.K. Bae, J.K. Ahn, E.M. Koh, and H.S. Cha. 2012. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis. Inflammation 35: 633–637.
Lu, X.X., K.S. McCoy, J.L. Xu, W.K. Hu, and H.B. Chen. 2013. Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness. Inflammation 36: 582–591.
Bhorade, S.M., H. Chen, L. Molinero, C. Liao, E.R. Garrity, W.T. Vigneswaran, R. Shilling, A. Sperling, A. Chong, and M.L. Alegre. 2010. Decreased percentage of CD4 + FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 90: 540–546.
Sun, J., Z.B. Han, W. Liao, S.G. Yang, Z. Yang, J. Yu, L. Meng, R. Wu, and Z.C. Han. 2011. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4 + CD25+ Forkhead Boxp3 (FOXP3) + regulatory T cells and balancing anti- and pro-inflammatory factors. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 27: 587–596.
Holm, T.L., J. Nielsen, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: I. Phenotype and physiology. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 629–641.
Nielsen, J., T.L. Holm, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 642–650.
Tang, L., J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1. Journal of Leukocyte Biology 96: 809–20.
Tang, L., L. Tang, J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. PD-L1 regulates the Tregs’ capacity to repress shock/sepsis induced indirect lung injury (iALI) by recruiting phosphatase SHP-1. Shock (Augusta, Ga.). doi:10.1189/4MA1213-647RR.
Conflict of Interest
No competing financial interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, H., Zhou, Y., Li, G. et al. Regulatory T Cells Contribute to the Recovery of Acute Lung Injury by Upregulating Tim-3. Inflammation 38, 1267–1272 (2015). https://doi.org/10.1007/s10753-014-0096-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-0096-7